Stoke Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Stoke Therapeutics Stock Summary

Stoke Therapeutics competes with Adaptimmune Therapeutics, Black Diamond, Relay Therapeutics, Pliant Therapeutics, and Arvinas. Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide medicines to treat the underlying causes of severe genetic diseases in the United States. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts. Stoke Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.

Stoke Therapeutics Key Financial Ratios

Stoke Therapeutics Key Balance Sheet Accounts

Stoke Therapeutics Key Income Statement Accounts

Stoke Therapeutics Key Cash Accounts

Stoke Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Stoke Therapeutics's current stock value. Our valuation model uses many indicators to compare Stoke Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Stoke Therapeutics competition to find correlations between indicators driving Stoke Therapeutics's intrinsic value. More Info.Stoke Therapeutics is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . At this time, Stoke Therapeutics' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Stoke Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Stoke Therapeutics Systematic Risk

Today, most investors in Stoke Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Stoke Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Stoke Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Stoke Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Stoke Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Stoke Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Stoke Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Stoke Therapeutics's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.